Clinical Trials Logo

Clinical Trial Summary

The REFRESH study is designed to collect data related to a signal in the brain that MindRhythm has named the Headpulse. The Headpulse occurs as a natural movement of the brain in conjunction with the beating of the heart. 500 "normal" subjects who are considered healthy as they do not have any current known neurological injury will collect the brain signal data from the non-invasive headband style headset for a duration of 3 minutes either once or multiple times. Upon consenting to participate to the study by way of the accompanying MindRhythm app, participants will be sent a Harmony headset kit which will include ECG leads to collect cardiac data in conjunction with the brain signal. The participant will receive training materials and instructions on how to collect and transmit data to investigators by way of the MindRhythm app. The data collected by these "normal" patients will be used as a comparator to individuals who are suspected of neurological injury. This data will assist in training the data analysis algorithm to optimize its diagnostic abilities in detecting neurological injury or abnormalities including but not limited to stroke, stroke type, and concussion. The data set will also be analyzed to determine how the signal varies within an individual and amongst other "normals." An additional benefit of collecting this data will be to gain knowledge related to the ergonomic factors of the app and the headset and its "user friendliness."

Clinical Trial Description

This study will involve recordings using MindRhythm's Harmony 4000, a novel, non-invasive investigative medical device. The Harmony 4000 collects accelerometry data on the motion of the skull resulting from the movement of the brain during each cardiac cycle. The motion of the skull due to brain movement is named the HeadPulse by MindRhythm. The HeadPulse, cranial accelerometry, has been shown to provide clinically relevant data for concussion, vasospasm and Large Vessel Occlusion (LVO) stroke (Wade Smith, 2015). The Harmony 4000 is a headband and is self-contained. Control of the device is provided by pushbuttons (on and off) on the headband and via an MindRhythm iPhone app. The objective of this non-significant risk (NSR) study is to collect HeadPulse waveform recordings from 500 normal subjects to be used as controls when developing algorithms for trials in stroke, concussion and other neurological conditions. The data set of normal subjects will allow evaluation of repeatability and variability of HeadPulse recordings within a subject and between subjects. Collecting un-blinded HeadPulse waveform with the Harmony 4000 from normal adult subjects including and above the ages of 18 during normal circumstances will create a comparative cohort. These normal data sets will assist in improving the diagnostic capabilities of the Harmony 4000 device in detecting neurological abnormalities including but not limitied to stroke, stroke type, and concussion. These subjects will be recorded once or multiple times as a time series covering recordings up to two years in duration. A secondary endpoint will be to determine the quality of recordings obtained when subjects are permitted to make their own recordings without supervision after iPhone app based training. Participant's will be recruited to volunteer to provide intracranial waveform data with the understanding that they are considered "healthy" subjects. Upon downloading the iPhone MindRhythm study app, subjects will be asked a series of questions related to inclusion and exclusion criteria, and presented with a consent form that describes the study, and what will be asked of them. Upon subject's direct consent (no LARS) to participate in the study, participant will be enrolled and sent a Harmony headset kit that will include brief training instructions for both the use of the headset and the iPhone app, ECG leads and the Harmony headset. Participant will follow the instructions and provide recordings by way of the app at the same time of day and based on a specified physical position that will suggested and recorded in the app. The subject will be instructed as to how to connect the ECG leads and place the pads on the chest and abdomen. As the "Headpulse" which is the intracranial waveform detected by the Harmony headset and is as a result of the natural movement of the brain immedliately following the cardiac cycle, the ECG data must also be recorded in conjunction with the cranial readings. The subject will connect the headset to their app by way of bluetooth once a position has been chosen and leads are connected. Upon connection, the subject will maintain a still and quiet position for a period of 3 minutes while the app collects the waveform data. Upon completion of the 3 minutes, an audible chime will occur and data will stop being transmitted and recorded. The subject will then transmit that data under their patient ID number to study investigators by way of a HIPAA compliant cloud based transmission and storage system. The subject has the option to withdraw from the study at any time by way of the iPhone app and/or the PI has the option to withdraw the subject from the study. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05203393
Study type Observational
Source MindRhythm, Inc.
Contact Paul Lovoi, PhD
Phone 8608368630
Status Not yet recruiting
Start date January 15, 2023
Completion date January 15, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1